Mr. Wald et al., PARTICIPATION OF NITRIC-OXIDE AND CYCLIC-GMP IN THE SUPERSENSITIVITY OF ACUTE DIABETIC RAT MYOCARDIUM BY CHOLINERGIC STIMULI, Biochemical pharmacology, 55(12), 1998, pp. 1991-1999
The purpose of this study was to explore the pharmacological and bioch
emical mechanisms involved in diabetic cardiomyopathy, with particular
interest in the abnormal function of cholinergic neurotransmission at
the onset of the pathology. The muscarinic acethylcholine agonist car
bachol showed a negative inotropic response on both normal and diabeti
c isolated atria, but the latter showed a supersensitive response. No
changes were found in muscarinic acethylcholine receptor (mAChR) expre
ssion. Measurements of mAChR associated second messengers indicated no
significant differences between normal and diabetic rat atria in the
stimulatory effect of carbachol on protein kinase C activity and the p
roduction of inositol phosphates, or in the inhibitory effect induced
by carbachol on cyclic AMP (cAMP) production. On the contrary, nitric
oxide (NO) synthase activity and cyclic GMP production were higher in
diabetic cardiac preparations than in normal ones. Moreover, in diabet
ic atria, nitric oxide synthase and guanylate cyclase inhibitors shift
ed the carbachol concentration-response curve on contractility to the
right, reaching values similar to those of normal atria. These results
suggest an early alteration in the mACh system during the diabetic st
ate, associated with increased production of nitric oxide and cyclic G
MP (cGMP). This, in rum, could increase the biological mechanical acti
vity of the mAChR agonist, inducing in this way a higher pharmacologic
al response, without changes in mAChR expression. BIOCHEM PHARMACOL 55
;12:1991-1999, 1998. (C) 1998 Elsevier Science Inc.